Amphera news

Amphera announces results of randomized phase II/III trial with MesoPher cell therapy in pleural mesothelioma, published in The Lancet Oncology

Amphera B.V., a late-stage biotechnology company developing MesoPher cell therapy to treat cancer, today announces publication of the results of […]